Results 271 to 280 of about 20,308 (302)

Moxifloxacin 0.5% Ophthalmic Solution

Drugs, 2011
The fourth-generation 8-methoxyfluoroquinolone moxifloxacin is available as an 0.5% ophthalmic solution for use in the treatment of bacterial conjunctivitis. Moxifloxacin had good activity against various Gram-positive and -negative ocular isolates in vitro, and moxifloxacin 0.5% ophthalmic solution achieved good penetration into ocular tissues in ...
openaire   +3 more sources

Older adult participation in cancer clinical trials: A systematic review of barriers and interventions

Ca-A Cancer Journal for Clinicians, 2021
Mina S Sedrak, Rachel A Freedman, Aminah Jatoi   +2 more
exaly  

Ophthalmic Otrivin Solution*

American Journal of Ophthalmology, 1960
openaire   +3 more sources

Preparation of Ophthalmic Solutions [PDF]

American Journal of Health-System Pharmacy, 1959
openaire   +1 more source

Framing “nature‐based” solutions to climate change

Wiley Interdisciplinary Reviews: Climate Change, 2021
Noel Castree, Rob Bellamy, Shannon Osaka
exaly  

Electrolyte solutions design for lithium-sulfur batteries

Joule, 2021
Ruqiang Zou, Quanquan Pang
exaly  

Compounding OPHTHALMIC SOLUTIONS*

Journal of the American Pharmaceutical Association (Practical Pharmacy ed.), 1955
Masao Okumoto, Sidney Riegelman, Daniel G. Vaughan   +2 more
openaire   +2 more sources

Self-Sterilizing Ophthalmic Solutions*

American Journal of Ophthalmology, 1949
Samuel D. McPherson, Ronald M. Wood
openaire   +3 more sources

Two Ophthalmic Solutions

JAMA, 2001
openaire   +2 more sources

Noncoding RNA therapeutics — challenges and potential solutions

Nature Reviews Drug Discovery, 2021
Sherien M El-daly, Muller Fabbri, George A Calin   +2 more
exaly